Agnirva Space Premier League - Expedition #32356: Tiny Tools for Big Problems: Nanoparticles and Alzheimer’s Research in Space
- Agnirva.com

- Aug 1
- 2 min read
Can tiny particles help us tackle huge medical challenges? That’s the question the ISS experiment on precision-manufactured nanoparticles aimed to answer—particularly in the context of treating orphan and chronic diseases like Alzheimer’s.
Led by Dr. Trevor Castor from Aphios Corporation and facilitated by Space Technology and Advanced Research Systems, Inc., this study utilized the unique microgravity environment aboard the ISS during Expeditions 59/60. The focus was on Green SuperFluids Technology—an environmentally friendly method for manufacturing targeted nanoparticles.
Nanoparticles are incredibly small—thousands of times smaller than a human hair—but they can be engineered to carry drugs directly to diseased cells. In space, the lack of gravity allows researchers to study the self-assembly and behavior of these particles in ways not possible on Earth. This leads to more uniform and precise nanoparticle designs.
Alzheimer’s Disease, a debilitating neurodegenerative disorder, currently has no cure. Effective treatment is also limited by the difficulty in delivering drugs past the blood-brain barrier. Nanoparticles offer a promising solution, acting as microscopic couriers that can navigate these biological roadblocks.
The experiment also looked at how Green SuperFluids could improve nanoparticle production. Traditional chemical manufacturing can be harsh and polluting. SuperFluids technology uses natural, safe solvents to produce medical-grade particles with fewer contaminants and more consistency.
By combining cutting-edge materials science with the benefits of microgravity, this research opens new avenues for treating not only Alzheimer’s but also other difficult-to-treat conditions. The insights gained in orbit could revolutionize drug development and precision medicine on Earth.
Join the Agnirva Space Internship Program



Comments